May 24, 2017 / 8:39 PM / 4 months ago

BRIEF-Antibe Therapeutics announces proposed offering of units

May 24 (Reuters) - Antibe Therapeutics Inc

* Antibe therapeutics inc. Announces proposed offering of units

* Antibe therapeutics inc - proposed offering of units for minimum gross proceeds of $3 million and maximum gross proceeds of $5 million

* Antibe therapeutics inc - has filed a preliminary short form prospectus in connection with a proposed marketed offering of units of company

* Antibe therapeutics inc - intends to use net proceeds to complete its phase 2 gi safety study for company’s lead drug, atb-346

* Antibe therapeutics inc - also intends to use net proceeds to commence metabolic studies for atb-346 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below